Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1

Authors :: Allison Betof Warner
Alexander M. Menzies
Lauren E. Haydu
Jeewon Chon
Douglas B. Johnson
Minmin Li
Carrie Daniel-MacDougall
Alexander N. Shoushtari
Kenneth R. Hess
Michael A. Davies
Jennifer L. McQuade
Source :: Journal of Clinical Oncology. 36:9562-9562
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 9562Background: Obesity has recently been associated with improved outcomes in male, but not female, MM pts treated with single-agent anti-CTLA4 and with single-agent anti-PD1 immunotherapy. Howeve...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Metastatic melanoma
business.industry
medicine.medical_treatment
chemical and pharmacologic phenomena
Immunotherapy
medicine.disease
Obesity
Internal medicine
medicine
Overall survival
Anti ctla4
Anti pd1
business
Body mass index

Full Text Access

Tools